🔗 Permalink

Assignee profile:

BIOATLA, LLC

City:

San Diego, California

Country:

United States

Published Applications:

Last publication date:

2021-07-29

Patent Grants:

Last grant date:

2022-10-18

Top Inventors for applications by BIOATLA, LLC

These are the the leading inventors for applications assigned to BIOATLA, LLC:

Jay M. Short 37 Del Mar, CA United States
Gerhard Frey 24 San Diego, CA United States
Hwai Wen Chang 24 San Marcos, CA United States
Jay Milton Short 4 Del Mar, CA United States

Jay Short 3 Del Mar, CA United States
William Boyle 2 Malibu, CA United States
Richard A. Miller 1 Portola Valley, CA United States
Gerhard Johann Frey 1 San Diego, CA United States

Jay M. Short 1 Jackson, WY United States
Emily Piccione Griffin 1 Belmont, CA United States
Gregory Frost 1 Del Mar, CA United States
Jay M. Short 1 Jackson, CA United States

HWAI WEN CHANG 1 SAN MARCO, CA United States

Recent patent applications by BIOATLA, LLC

BIOATLA, LLC based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-07-29

US20210230221A1

Chemistry; metallurgy

PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS

#2 | 2020-12-31 ✅ Patent 11,472,876 granted on 2022-10-18

US20200407439A1

Chemistry; metallurgy

Conditionally active polypeptides

#3 | 2020-08-13 ✅ Patent 11,396,717 granted on 2022-07-26

US20200256875A1

Physics

Comprehensive monoclonal antibody generation

#4 | 2020-07-09

US20200216834A1

Chemistry; metallurgy

DISCOVERING AND PRODUCING CONDITIONALLY ACTIVE BIOLOGIC PROTEINS IN THE SAME EUKARYOTIC CELL PRODUCTION HOSTS

#5 | 2020-06-25 ✅ Patent 11,254,932 granted on 2022-02-22

US20200199578A1

Chemistry; metallurgy

Conditionally active biological proteins

#6 | 2020-06-18 ✅ Patent 11,279,924 granted on 2022-03-22

US20200190503A1

Chemistry; metallurgy

Conditionally active polypeptides and methods of generating them

#7 | 2020-05-21 ✅ Patent 11,396,556 granted on 2022-07-26

US20200157247A1

Chemistry; metallurgy

Express humanization of antibodies

#8 | 2020-01-02 ✅ Patent 11,254,742 granted on 2022-02-22

US20200002414A1

Chemistry; metallurgy

Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof

#9 | 2019-09-19

US20190284551A1

Chemistry; metallurgy

Conditionally Active Biological Proteins

#10 | 2019-06-13 ✅ Patent 11,149,088 granted on 2021-10-19

US20190177417A1

Chemistry; metallurgy

Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof

#11 | 2019-05-23 ✅ Patent 10,696,750 granted on 2020-06-30

US20190153120A1

Chemistry; metallurgy

Multi-specific monoclonal antibodies

#12 | 2019-03-14 ✅ Patent 10,822,426 granted on 2020-11-03

US20190077873A1

Chemistry; metallurgy

Humanized anti-CD73 antibodies

#13 | 2019-01-24 ✅ Patent 10,563,194 granted on 2020-02-18

US20190024078A1

Chemistry; metallurgy

Conditionally active biological proteins

#14 | 2019-01-10 ✅ Patent 11,111,288 granted on 2021-09-07

US20190010220A1

Chemistry; metallurgy

Conditionally active chimeric antigen receptors for modified t-cells

#15 | 2019-01-10

US20190010219A1

Chemistry; metallurgy

Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

#16 | 2018-12-27 ✅ Patent 10,920,216 granted on 2021-02-16

US20180371452A1

Chemistry; metallurgy

Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts

#17 | 2018-12-20 ✅ Patent 10,829,513 granted on 2020-11-10

US20180362576A1

Chemistry; metallurgy

Methods of protein evolution

#18 | 2018-11-29 ✅ Patent 11,584,927 granted on 2023-02-21

US20180340021A1

Chemistry; metallurgy

Conditionally active chimeric antigen receptors for modified T-cells

#19 | 2018-09-13 ✅ Patent 11,293,929 granted on 2022-04-05

US20180259536A1

Physics

Proteins targeting orthologs

#20 | 2018-08-23

US20180237543A1

Chemistry; metallurgy

MULTI-SPECIFIC MONOCLONAL ANTIBODIES

#21 | 2018-07-05 ✅ Patent 10,954,288 granted on 2021-03-23

US20180186863A1

Chemistry; metallurgy

Modified antibody regions and uses thereof

#22 | 2018-03-29

US20180086843A1

Chemistry; metallurgy

ANTI-CD22 ANTIBODIES

#23 | 2017-12-28 ✅ Patent 11,718,844 granted on 2023-08-08

US20170369867A1

Chemistry; metallurgy

Mirac proteins

#24 | 2017-09-14

US20170260261A1

Chemistry; metallurgy

Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

#25 | 2017-08-31 ✅ Patent 10,513,699 granted on 2019-12-24

US20170247685A1

Chemistry; metallurgy

Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts

#26 | 2017-08-31 ✅ Patent 10,562,981 granted on 2020-02-18

US20170247473A1

Chemistry; metallurgy

Express humanization of antibodies

#27 | 2017-07-13 ✅ Patent 10,697,972 granted on 2020-06-30

US20170199198A1

Physics

Diagnostics using conditionally active antibodies

#28 | 2017-07-06 ✅ Patent 10,329,556 granted on 2019-06-25

US20170191055A1

Chemistry; metallurgy

Conditionally active biological proteins

#29 | 2017-02-16 ✅ Patent 9,994,841 granted on 2018-06-12

US20170044522A1

Chemistry; metallurgy

Mirac proteins

#30 | 2016-07-21

US20160207989A1

Chemistry; metallurgy

CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS

#31 | 2015-09-10 ✅ Patent 9,969,813 granted on 2018-05-15

US20150252119A1

Chemistry; metallurgy

Multi-specific monoclonal antibodies

#32 | 2015-03-26 ✅ Patent 9,856,323 granted on 2018-01-02

US20150086562A1

Chemistry; metallurgy

Anti-CD22 antibodies

#33 | 2015-01-22 ✅ Patent 10,047,357 granted on 2018-08-14

US20150024944A1

Chemistry; metallurgy

Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts

#34 | 2014-12-25 ✅ Patent 9,982,252 granted on 2018-05-29

US20140378660A1

Chemistry; metallurgy

Mirac proteins

#35 | 2014-12-04 ✅ Patent 9,637,735 granted on 2017-05-02

US20140356344A1

Chemistry; metallurgy

Mirac proteins

#36 | 2014-07-03 ✅ Patent 9,637,734 granted on 2017-05-02

US20140187748A1

Physics

Mirac proteins

#37 | 2013-11-14 ✅ Patent 9,683,054 granted on 2017-06-20

US20130303399A1

Chemistry; metallurgy

Express humanization of antibodies

#38 | 2013-10-24 ✅ Patent 10,670,608 granted on 2020-06-02

US20130281303A1

Physics

Comprehensive monoclonal antibody generation

#39 | 2013-05-09 ✅ Patent 10,106,576 granted on 2018-10-23

US20130116125A1

Chemistry; metallurgy

Methods of protein evolution

#40 | 2012-10-11 ✅ Patent 8,709,755 granted on 2014-04-29

US20120258865A1

Chemistry; metallurgy

Mirac proteins

#41 | 2012-09-27 ✅ Patent 10,106,788 granted on 2018-10-23

US20120245036A1

Chemistry; metallurgy

Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts

#42 | 2012-06-28 ✅ Patent 8,859,467 granted on 2014-10-14

US20120165201A1

Chemistry; metallurgy

Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts

#43 | 2012-06-28 ✅ Patent 9,464,284 granted on 2016-10-11

US20120164127A1

Chemistry; metallurgy

Mirac proteins

#44 | 2010-10-14

US20100260739A1

Chemistry; metallurgy

Mirac Proteins

#45 | 2010-06-03 ✅ Patent 8,062,866 granted on 2011-11-22

US20100138945A1

Chemistry; metallurgy

Humanized anti-IL-6 antibodies

Also check out BioAtla, LLC's (San Diego, United States) applicant profile with 23 patent applications submitted.

AssigneeID:

21818 ⎘